Interim Infection Prevention and Control Recommendations for Hospitalized Patients with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Standard, contact, and airborne precautions are recommended for management of hospitalized patients with known or suspected MERS-CoV infection, based on CDC's case definition for patient under investigation.
These recommendations are consistent with those recommended for the coronavirus that caused severe acute respiratory syndrome (SARS). As information becomes available, these recommendations will be re-evaluated and updated as needed.
These recommendations are based upon available information (as of May 2, 2014) and the following considerations:
- Suspected high rate of morbidity and mortality among infected patients
- Evidence of limited human-to-human transmission
- Poorly characterized clinical signs and symptoms
- Unknown modes of transmission of MERS-CoV
- Lack of a vaccine and chemoprophylaxis
- Absence of confirmed or probable MERS-CoV cases in the United States
Selected Components of Standard, Contact, and Airborne Precautions Recommended for Prevention of MERS-CoV Transmission in Hospitals
For full details of these precautions, see 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Setting.
Personal Protective Equipment (PPE) for Healthcare personnel (HCP)
Environmental Infection Control
To aid providers and facilities, CDC has developed two checklists that identify key actions that can be taken now to enhance preparedness for MERS-CoV infection control.
Interim Home Care and Isolation Guidance
CDC has developed interim guidance for local and state health departments, infection prevention and control professionals, healthcare providers, and healthcare workers who are coordinating the home care and isolation of ill people who are being evaluated for MERS-CoV infection.